Total Payments
$8,260
2024 Payments
$25.00
Companies
32
Transactions
463
Medicare Patients
15,514
Medicare Billing
$3.2M
Payment Breakdown by Category
Food & Beverage$8,017 (97.0%)
Education$243.77 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,017 | 425 | 97.0% |
| Education | $243.77 | 38 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,466 | 54 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $934.37 | 52 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $763.60 | 39 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $749.70 | 53 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $684.86 | 61 | $0 (2020) |
| PFIZER INC. | $659.57 | 64 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $625.66 | 39 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $525.14 | 33 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $298.62 | 19 | $0 (2019) |
| Ablacon, Inc. | $241.24 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25.00 | 1 | E.R. Squibb & Sons, L.L.C. ($25.00) |
| 2023 | $241.24 | 1 | Ablacon, Inc. ($241.24) |
| 2021 | $11.72 | 1 | Amgen Inc. ($11.72) |
| 2020 | $731.11 | 29 | Medicure Pharma Inc. ($227.81) |
| 2019 | $2,612 | 156 | Amgen Inc. ($586.95) |
| 2018 | $2,093 | 125 | Amgen Inc. ($466.37) |
| 2017 | $2,546 | 150 | Amgen Inc. ($381.79) |
All Payment Transactions
463 individual payment records from CMS Open Payments — Page 3 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/14/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Cardiology | ||||||
| 11/07/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Education | In-kind items and services | $7.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Education | In-kind items and services | $7.08 | General |
| Category: DIABETES | ||||||
| 11/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/31/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/31/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $1.28 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/30/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.45 | General |
| Category: Cardiovascular | ||||||
| 10/30/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/17/2019 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: Cardiology | ||||||
| 10/16/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Anemia | ||||||
| 10/15/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/15/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Education | In-kind items and services | $7.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Education | In-kind items and services | $7.08 | General |
| Category: DIABETES | ||||||
| 10/10/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.87 | General |
| Category: Cardiovascular | ||||||
| 10/10/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2019 | PFIZER INC. | VYNDAQEL (Drug) | Education | In-kind items and services | $7.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $2.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $0.47 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/04/2019 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/02/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 4,030 | 5,706 | $3.4M | $822,294 |
| 2022 | 32 | 3,987 | 5,730 | $3.1M | $784,403 |
| 2021 | 34 | 3,893 | 5,745 | $3.2M | $839,534 |
| 2020 | 30 | 3,604 | 5,765 | $2.8M | $709,301 |
Total Patients
15,514
Total Services
22,946
Medicare Billing
$3.2M
Procedure Codes
126
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 2 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 60 | 63 | $3,969 | $802.11 | 20.2% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 12 | 12 | $1,128 | $307.20 | 27.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 24 | 24 | $5,184 | $259.92 | 5.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 908 | 1,617 | $768,075 | $253,199 | 33.0% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2022 | 97 | 97 | $832,939 | $149,743 | 18.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 637 | 672 | $565,890 | $125,088 | 22.1% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2022 | 98 | 194 | $159,080 | $81,045 | 50.9% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2022 | 134 | 135 | $139,725 | $29,572 | 21.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 146 | 146 | $97,820 | $29,513 | 30.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 99 | 396 | $59,972 | $19,196 | 32.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 73 | 157 | $45,687 | $12,300 | 26.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 64 | 126 | $45,108 | $11,428 | 25.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 562 | 826 | $65,254 | $10,203 | 15.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 73 | $25,769 | $7,680 | 29.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 38 | 41 | $28,290 | $7,047 | 24.9% |
| 76376 | 3d radiographic procedure | Office | 2022 | 244 | 254 | $83,058 | $5,901 | 7.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 26 | 26 | $26,130 | $5,049 | 19.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 22 | 22 | $15,268 | $4,445 | 29.1% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2022 | 20 | 47 | $15,772 | $3,791 | 24.0% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2022 | 32 | 77 | $9,815 | $3,666 | 37.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 52 | 52 | $17,472 | $3,540 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 37 | $8,880 | $2,725 | 30.7% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2022 | 103 | 107 | $9,202 | $2,336 | 25.4% |
| 93356 | Heart muscle strain imaging | Office | 2022 | 51 | 55 | $9,735 | $2,180 | 22.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 95 | 96 | $6,816 | $1,953 | 28.7% |
About Dr. Bruce Benedick, M.D
Dr. Bruce Benedick, M.D is a Interventional Cardiology healthcare provider based in E Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346274602.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Benedick, M.D has received a total of $8,260 in payments from pharmaceutical and medical device companies, with $25.00 received in 2024. These payments were reported across 463 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($8,017).
As a Medicare-enrolled provider, Benedick has provided services to 15,514 Medicare beneficiaries, totaling 22,946 services with total Medicare billing of $3.2M. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Nuclear Cardiology, Cardiovascular Disease
- Location E Palo Alto, CA
- Active Since 07/10/2006
- Last Updated 05/28/2020
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1346274602
Products in Payments
- ELIQUIS (Drug) $1,451
- Corlanor (Drug) $848.72
- XARELTO (Drug) $732.75
- ENTRESTO (Drug) $625.66
- Repatha (Biological) $617.42
- PRALUENT (Drug) $580.21
- BRILINTA (Drug) $525.14
- PRADAXA (Drug) $508.21
- Heart Failure Device. (Device) $227.81
- MULTAQ (Drug) $183.39
- JARDIANCE (Drug) $176.65
- PRALUENT (Biological) $160.72
- PRALUENT ALIROCUMAB INJECTION (Biological) $137.90
- VYNDAQEL (Drug) $122.12
- KENGREAL (Drug) $117.44
- Circulatory Support (Device) $106.27
- WATCHMAN (Device) $99.45
- LifeVest (Device) $74.09
- Veltassa (Drug) $58.45
- Vascepa (Drug) $56.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.